Russia Pushes Radical Longevity Research Amid Heavy Casualties in Ukraine
While facing heavy losses in Ukraine, Russia is heavily investing in anti-aging research and longevity initiatives championed by President Vladimir Putin and his inner circle.
Russia is heavily investing in anti-aging and longevity research under the personal drive of President Vladimir Putin, while simultaneously suffering severe military casualties in Ukraine. According to Ukrainian reports, over 54,000 Russian soldiers were killed or wounded in October alone, marking a record high since the invasion began nearly five years ago.
While the war continues to drain human resources, the Russian establishment is pouring substantial funding into life-extension initiatives. A central figure in these efforts is Dr. Maria Vorontsova, Putin's eldest daughter and a senior endocrinologist heading the Medical Research and Education Institute at Moscow University. Although Putin has never publicly confirmed her identity, the US Treasury placed her under sanctions in 2022, citing her leadership in Kremlin-backed genetic research programs.
At a forum held at the Skolkovo School of Management in Moscow, Dr. Vorontsova outlined a two-stage longevity strategy. The first phase focuses on realizing the body's natural potential, estimated at 85 to 90 years, through healthy habits and regular medical checkups. The second, more ambitious phase aims to bypass biological limits and achieve radical life extension. She noted that while aging is not yet legally classified as a disease—complicating drug development—universal fear of death will inevitably push healthcare systems toward anti-aging solutions.
Putin himself announced a national project titled "New Health Preservation Technologies" alongside the "Long and Active Life" initiative, with Russia planning to allocate over two trillion rubles to both programs. State initiatives include genetic research, bioprinting of human tissues, and developing what officials describe as an "anti-aging vaccine." Deputy Prime Minister Tatiana Golikova previously stated that Russia aims to produce an anti-aging drug between 2028 and 2030, with a stated goal of saving 175,000 lives by the end of the decade.
The state-backed pursuit of immortality has distinct political undertones. Putin, aged 74, has long shown a keen interest in rejuvenation therapies. During a military parade in Beijing in September 2025, a hot microphone captured him discussing radical life extension with Chinese President Xi Jinping. Xi remarked that a 70-year-old today is "still a child," while Putin responded through an interpreter that biotechnology will eventually allow continuous organ replacement and potentially grant humanity immortality.
Alongside Dr. Vorontsova, physicist Mikhail Kovalchuk—head of the Kurchatov Institute and brother of a close Putin ally—oversees federal genetic research programs. However, the scientific community remains skeptical. Critics note that unlike privately funded longevity research in the West, Russian state-backed projects lack peer-reviewed publications in leading international journals, leading some experts to suggest that researchers are simply telling the aging leadership what it wants to hear.
